The French study included 30,202 patients.

COVID patients who were treated with hydroxychloroquine were less likely to die than those who weren’t, according to a new study.

Just 0.8 percent of patients at a facility in France who received hydroxychloroquine (HCQ) and an antibiotic died, compared with 4.8 percent of patients who didn’t receive the drug combination, French researchers reported on Nov. 1.

“This study represents the largest single-center study evaluating HCQ-AZ in the treatment of COVID-19,” Dr. Didier Raoult, with Aix-Marseille Universite in Marseille, and his co-authors wrote. “Similarly, to other large observational studies, it concludes that HCQ would have saved lives.”